Alteon (ALT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alteon (ALT)

ALT 3.860

-3.0%

Dec 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tnsaf who wrote (298)	1/4/2001 5:11:29 AM
From: scott_jiminez	Read Replies (1) of 318

Results also show a clinically relevant increase in large artery compliance, an indicator of greater vascular flexibility and volume capacity, using a traditional measurement of the ratio of stroke volume to pulse pressure. Impressive. Seems to me a partnership between Alteon and Hypertension Diagnostics (HDII) is a no-brainer. HDII recently won FDA approval for their 'Profilor', a device which provides precise and reliable data for CV integrity. In other words, it measures DIRECTLY arterial flexibility etc. rather than indirectly deducing vascular health from the 'ratio of stroke volume to pulse pressure' The kicker is that HDII's device involves a 30 second test (in an office setting) because it is non-invasive. A before and after ALT-711 treatment report using HDII's Profilor would likely be a boon to both companies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next